Coronavirus On January 7, 2020, a novel coronavirus (2019-nCoV) was identified in humans in Wuhan City, …

In the NEWS: Coronavirus Yesterday the CDC announced the first US case of coronavirus which has …

Outperforming Prohost Picks  January 16, 2020 at 11:30 am EST MRNA Trading at $21.35 UP $1.01 …

A Comprehensive Essay Part 2 In Part 1 of our comprehensive essay series Vertex Pharmaceuticals (VRTX) …

Nektar Therapeutics and Bristol-Myers Squibb Agreement Nektar Therapeutics (NKTR) and Bristol-Myers Squibb (BMY) announced their agreement …

A Comprehensive Essay Part 1 Yes, we have stories to tell about some of our picked …

Prohost Letter #438 End of the Year Issue  2019 Happy New Year 2020 The NASDAQ reached …

Cassava Sciences: PTI-125 for Alzheimer's Disease Cassava Sciences (SAVA), a clinical-stage biopharmaceutical company focused on Alzheimer’s disease, …

More from the Prohost Portfolio with Our Observations Gilead (GILD) has cash and new products reaching …

Amylyx Pharmaceuticals With the advancement of biological sciences, and increased information about the pathways of diseases, …